Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Molecular Diagnostics

Test Will Identify ALK Inhibitor-Resistance Mutations

A test will identify resistance mutations in lung cancer patients undergoing anaplastic lymphoma kinase-inhibitor therapy. More...
20 Oct 2011

Laboratory Provides Exome Sequencing Services for Clinical Diagnostics Applications

Clinical Diagnostic Exome sequencing is available on a clinical basis along with clinical interpretation and classification of variant data. More...
19 Oct 2011

Pregnancy Zone Protein Found in Women Before AD Develops

Scientists have discovered that older women destined to develop Alzheimer's disease have high blood levels of a protein linked to pregnancy years before showing symptoms. More...
18 Oct 2011

Gene Mutation Discovered for Some Blood Cancers

A gene involved in the modification of RNA is mutated in a significant proportion of people within a group of blood cancers. More...
12 Oct 2011

Novel Method for Detecting Lung Cancer

A highly sensitive technology can detect lung cancer by identifying a specific small ribonucleic acid in the bloodstream, according to a new study. More...
10 Oct 2011

Diagnostic Test for AD Based on Peripheral Biochemical Marker

A straightforward and economic diagnostic test for Alzheimer’s disease is based on a peripheral biochemical marker. More...
06 Oct 2011

Specific Molecule Detected in Bloodstream of Lung Cancer Patients

A specific small ribonucleic acid molecule is often elevated in lung cancer patients. More...
29 Sep 2011
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
8-Channel Pipette
SAPPHIRE 20–300 µL
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88


Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
Copyright © 2000-2026 Globetech Media. All rights reserved.